Bolt Biotherapeutics, Inc. (BOLT) vs Synlogic, Inc. (SYBX)
Bolt Biotherapeutics, Inc. and Synlogic, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Synlogic, Inc. are of similar size ($6.9M and $6.7M). Synlogic, Inc. grew revenue faster over the last twelve months: 188.7% against 12.8%. Synlogic, Inc. has the higher net margin (0.00% vs −611.5%) and the higher return on invested capital (0.00% vs −143.8%). Across the 17 metrics below, Synlogic, Inc. leads on 12 and Bolt Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | BOLT | SYBX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (654.53%) | 0.00% | 0.00% |
| Net margin | (611.47%) | 0.00% | 0.00% |
| Free cash flow margin | (655.72%) | 0.00% | 0.00% |
| Return on equity | (111.65%) | (5.32%) | (57.72%) |
| Return on assets | (49.62%) | (4.25%) | (49.22%) |
| Return on invested capital | (143.75%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack